Browsing Centre for Evaluation and Methods by Author "Thomas, KS"
Now showing items 1-3 of 3
-
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
Pyne, S; Sach, TH; Lawrence, M; Renz, S; Eminton, Z; Stuart, B; Thomas, KS; Francis, N; Soulsby, I; Thomas, K (BMJ Publishing Group, 2023-12-11)OBJECTIVE: This study aims to estimate the cost-effectiveness of oral spironolactone plus routine topical treatment compared with routine topical treatment alone for persistent acne in adult women from a British NHS ... -
Do patient characteristics matter when calculating sample size for eczema clinical trials?
Howells, L; Gran, S; Chalmers, JR; Stuart, B; Santer, M; Bradshaw, L; Gaunt, DM; Ridd, MJ; Gerbens, LAA; Spuls, PI (2021-09)BACKGROUND: The Patient-Oriented Eczema Measure (POEM) is the core outcome instrument recommended for measuring patient-reported atopic eczema symptoms in clinical trials. To ensure that the statistical significance of ... -
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Renz, S; Chinnery, F; Stuart, B; Day, L; Muller, I; Soulsby, I; Nuttall, J; Thomas, K; Thomas, KS; Sach, T (2021)